pregabalin and Graft-vs-Host-Disease

pregabalin has been researched along with Graft-vs-Host-Disease* in 1 studies

Other Studies

1 other study(ies) available for pregabalin and Graft-vs-Host-Disease

Article	Year
Successful treatment of calcineurin inhibitor-induced pain syndrome with acute graft versus host disease by switching calcineurin inhibitors followed by pregabalin. Annals of hematology, 2017, Volume: 96, Issue:7 Topics: Aged; Calcineurin Inhibitors; Combined Modality Therapy; Cyclosporine; Drug Monitoring; Drug Therapy, Combination; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hip; Humans; Lower Extremity; Male; Myelodysplastic Syndromes; Pain; Pregabalin; Severity of Illness Index; Tacrolimus; Transplantation, Homologous; Treatment Outcome	2017

Article

Year

Successful treatment of calcineurin inhibitor-induced pain syndrome with acute graft versus host disease by switching calcineurin inhibitors followed by pregabalin.

Annals of hematology, 2017, Volume: 96, Issue:7

Topics: Aged; Calcineurin Inhibitors; Combined Modality Therapy; Cyclosporine; Drug Monitoring; Drug Therapy, Combination; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hip; Humans; Lower Extremity; Male; Myelodysplastic Syndromes; Pain; Pregabalin; Severity of Illness Index; Tacrolimus; Transplantation, Homologous; Treatment Outcome

2017